Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).
Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G; IMDIAB Group. Pozzilli P, et al. Diabetes Technol Ther. 2003;5(6):965-74. doi: 10.1089/152091503322641006. Diabetes Technol Ther. 2003. PMID: 14709198 Clinical Trial.
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.
Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group. Petrone A, et al. Among authors: pozzilli p. Diabetes Care. 2008 Mar;31(3):534-8. doi: 10.2337/dc07-1457. Epub 2007 Dec 4. Diabetes Care. 2008. PMID: 18056891
A novel insulin unit calculator for the management of type 1 diabetes.
Maurizi AR, Lauria A, Maggi D, Palermo A, Fioriti E, Manfrini S, Pozzilli P. Maurizi AR, et al. Among authors: pozzilli p. Diabetes Technol Ther. 2011 Apr;13(4):425-8. doi: 10.1089/dia.2010.0190. Epub 2011 Feb 28. Diabetes Technol Ther. 2011. PMID: 21355727 Clinical Trial.
Blue eyes as a risk factor for type 1 diabetes.
Di Stasio E, Maggi D, Berardesca E, Marulli GC, Bizzarri C, Lauria A, Portuesi R, Cavallo MG, Costantino F, Buzzetti R, Astorri E, Pitocco D, Songini M, Pozzilli P; IMDIAB Group. Di Stasio E, et al. Among authors: pozzilli p. Diabetes Metab Res Rev. 2011 Sep;27(6):609-13. doi: 10.1002/dmrr.1214. Diabetes Metab Res Rev. 2011. PMID: 21557441
C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study.
Buzzetti R, Cernea S, Petrone A, Capizzi M, Spoletini M, Zampetti S, Guglielmi C, Venditti C, Pozzilli P; DiaPep Trialists Group. Buzzetti R, et al. Among authors: pozzilli p. Diabetes. 2011 Nov;60(11):3067-72. doi: 10.2337/db10-0560. Epub 2011 Sep 6. Diabetes. 2011. PMID: 21896927 Free PMC article. Clinical Trial.
Diabetes-related autoantibodies in children with acute lymphoblastic leukemia.
Bizzarri C, Pinto RM, Pitocco D, Astorri E, Cappa M, Hawa M, Giannone G, Palermo A, Maddaloni E, Leslie DR, Pozzilli P; IMDIAB Group. Bizzarri C, et al. Among authors: pozzilli p. Diabetes Care. 2012 Mar;35(3):e23. doi: 10.2337/dc11-1946. Diabetes Care. 2012. PMID: 22355026 Free PMC article. No abstract available.
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence?
Palermo A, Maddaloni E, Pozzilli P. Palermo A, et al. Among authors: pozzilli p. Expert Opin Biol Ther. 2012 Jun;12(6):767-72. doi: 10.1517/14712598.2012.675324. Epub 2012 Apr 20. Expert Opin Biol Ther. 2012. PMID: 22515262 Review.
577 results